annual accounts payable:
$413.00M+$48.10M(+13.18%)Summary
- As of today (May 18, 2025), VRTX annual accounts payable is $413.00 million, with the most recent change of +$48.10 million (+13.18%) on December 31, 2024.
- During the last 3 years, VRTX annual accounts payable has risen by +$218.00 million (+111.79%).
- VRTX annual accounts payable is now at all-time high.
Performance
VRTX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$445.00M+$32.00M(+7.75%)Summary
- As of today (May 18, 2025), VRTX quarterly accounts payable is $445.00 million, with the most recent change of +$32.00 million (+7.75%) on March 31, 2025.
- Over the past year, VRTX quarterly accounts payable has increased by +$93.60 million (+26.64%).
- VRTX quarterly accounts payable is now at all-time high.
Performance
VRTX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VRTX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.2% | +26.6% |
| 3 y3 years | +111.8% | +156.3% |
| 5 y5 years | +371.4% | +341.9% |
VRTX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +111.8% | at high | +250.7% |
| 5 y | 5-year | at high | +371.4% | at high | +341.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
VRTX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $445.00M(+7.7%) |
| Dec 2024 | $413.00M(+13.2%) | $413.00M(+4.3%) |
| Sep 2024 | - | $395.80M(+20.7%) |
| Jun 2024 | - | $327.90M(-6.7%) |
| Mar 2024 | - | $351.40M(-3.7%) |
| Dec 2023 | $364.90M(+20.1%) | $364.90M(-2.9%) |
| Sep 2023 | - | $375.90M(+3.6%) |
| Jun 2023 | - | $363.00M(+12.3%) |
| Mar 2023 | - | $323.20M(+6.4%) |
| Dec 2022 | $303.90M(+55.8%) | $303.90M(+139.5%) |
| Sep 2022 | - | $126.90M(-35.9%) |
| Jun 2022 | - | $198.00M(+14.1%) |
| Mar 2022 | - | $173.60M(-11.0%) |
| Dec 2021 | $195.00M(+25.7%) | $195.00M(+52.5%) |
| Sep 2021 | - | $127.86M(+0.3%) |
| Jun 2021 | - | $127.53M(-0.2%) |
| Mar 2021 | - | $127.84M(-17.6%) |
| Dec 2020 | $155.10M(+77.0%) | $155.10M(+43.9%) |
| Sep 2020 | - | $107.79M(+6.2%) |
| Jun 2020 | - | $101.45M(+0.7%) |
| Mar 2020 | - | $100.70M(+14.9%) |
| Dec 2019 | $87.61M(-21.1%) | $87.61M(-5.3%) |
| Sep 2019 | - | $92.53M(+20.1%) |
| Jun 2019 | - | $77.05M(-6.3%) |
| Mar 2019 | - | $82.26M(-25.9%) |
| Dec 2018 | $110.99M(+50.0%) | $110.99M(+20.4%) |
| Sep 2018 | - | $92.15M(+11.0%) |
| Jun 2018 | - | $83.03M(+12.1%) |
| Mar 2018 | - | $74.06M(+0.1%) |
| Dec 2017 | $73.99M(+20.4%) | $73.99M(-4.1%) |
| Sep 2017 | - | $77.14M(+1.6%) |
| Jun 2017 | - | $75.94M(+20.3%) |
| Mar 2017 | - | $63.15M(+2.8%) |
| Dec 2016 | $61.45M(-18.0%) | $61.45M(+20.7%) |
| Sep 2016 | - | $50.91M(-0.8%) |
| Jun 2016 | - | $51.30M(-31.8%) |
| Mar 2016 | - | $75.22M(+0.4%) |
| Dec 2015 | $74.94M(+5.3%) | $74.94M(-5.0%) |
| Sep 2015 | - | $78.90M(+8.5%) |
| Jun 2015 | - | $72.70M(+67.0%) |
| Mar 2015 | - | $43.52M(-38.9%) |
| Dec 2014 | $71.19M(+44.3%) | $71.19M(+85.1%) |
| Sep 2014 | - | $38.47M(-30.5%) |
| Jun 2014 | - | $55.36M(+11.7%) |
| Mar 2014 | - | $49.57M(+0.5%) |
| Dec 2013 | $49.33M(-51.3%) | $49.33M(-4.3%) |
| Sep 2013 | - | $51.53M(+6.1%) |
| Jun 2013 | - | $48.57M(-18.5%) |
| Mar 2013 | - | $59.63M(-41.1%) |
| Dec 2012 | $101.29M(+35.7%) | $101.29M(+21.0%) |
| Sep 2012 | - | $83.73M(+41.1%) |
| Jun 2012 | - | $59.35M(-18.9%) |
| Mar 2012 | - | $73.23M(-1.9%) |
| Dec 2011 | $74.64M(+108.2%) | $74.64M(+51.6%) |
| Sep 2011 | - | $49.25M(-26.8%) |
| Jun 2011 | - | $67.28M(+92.9%) |
| Mar 2011 | - | $34.88M(-2.7%) |
| Dec 2010 | $35.85M(-3.1%) | $35.85M(+45.5%) |
| Sep 2010 | - | $24.64M(-47.0%) |
| Jun 2010 | - | $46.49M(+59.7%) |
| Mar 2010 | - | $29.12M(-21.3%) |
| Dec 2009 | $36.99M(-28.5%) | $36.99M(+85.3%) |
| Sep 2009 | - | $19.96M(-27.4%) |
| Jun 2009 | - | $27.49M(+21.1%) |
| Mar 2009 | - | $22.70M(-56.1%) |
| Dec 2008 | $51.76M | $51.76M(+64.5%) |
| Sep 2008 | - | $31.46M(-13.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | $36.34M(+16.2%) |
| Mar 2008 | - | $31.28M(-4.5%) |
| Dec 2007 | $32.75M(+113.1%) | $32.75M(+27.1%) |
| Sep 2007 | - | $25.76M(+45.1%) |
| Jun 2007 | - | $17.75M(+94.2%) |
| Mar 2007 | - | $9.14M(-40.5%) |
| Dec 2006 | $15.37M(+147.5%) | $15.37M(+115.1%) |
| Sep 2006 | - | $7.14M(-13.7%) |
| Jun 2006 | - | $8.28M(+32.2%) |
| Mar 2006 | - | $6.26M(+0.8%) |
| Dec 2005 | $6.21M(-6.8%) | $6.21M(-3.9%) |
| Sep 2005 | - | $6.46M(-31.5%) |
| Jun 2005 | - | $9.43M(+11.3%) |
| Mar 2005 | - | $8.47M(+27.2%) |
| Dec 2004 | $6.66M(-45.9%) | $6.66M(-29.9%) |
| Sep 2004 | - | $9.50M(+21.6%) |
| Jun 2004 | - | $7.82M(+1.0%) |
| Mar 2004 | - | $7.74M(-37.1%) |
| Dec 2003 | $12.31M(-26.5%) | $12.31M(+52.5%) |
| Sep 2003 | - | $8.07M(-12.9%) |
| Jun 2003 | - | $9.27M(-7.3%) |
| Mar 2003 | - | $10.00M(-40.3%) |
| Dec 2002 | $16.75M(+44.0%) | $16.75M(+37.6%) |
| Sep 2002 | - | $12.17M(+24.6%) |
| Jun 2002 | - | $9.76M(-10.5%) |
| Mar 2002 | - | $10.91M(-6.1%) |
| Dec 2001 | $11.63M(+37.8%) | $11.63M(+82.3%) |
| Sep 2001 | - | $6.38M(+0.2%) |
| Jun 2001 | - | $6.36M(+145.1%) |
| Mar 2001 | - | $2.60M(-69.2%) |
| Dec 2000 | $8.44M(-40.4%) | $8.44M(-73.1%) |
| Sep 2000 | - | $31.39M(+77.9%) |
| Jun 2000 | - | $17.64M(+28.2%) |
| Mar 2000 | - | $13.77M(-2.7%) |
| Dec 1999 | $14.15M(+405.4%) | $14.15M(+33.5%) |
| Sep 1999 | - | $10.60M(-9.4%) |
| Jun 1999 | - | $11.70M(+5.4%) |
| Mar 1999 | - | $11.10M(+296.4%) |
| Dec 1998 | $2.80M(-33.3%) | $2.80M(-66.3%) |
| Sep 1998 | - | $8.30M(+38.3%) |
| Jun 1998 | - | $6.00M(-3.2%) |
| Mar 1998 | - | $6.20M(+47.6%) |
| Dec 1997 | $4.20M(+200.0%) | $4.20M(-50.6%) |
| Sep 1997 | - | $8.50M(+57.4%) |
| Jun 1997 | - | $5.40M(-14.3%) |
| Mar 1997 | - | $6.30M(+350.0%) |
| Dec 1996 | $1.40M(-53.3%) | $1.40M(-51.7%) |
| Sep 1996 | - | $2.90M(-29.3%) |
| Jun 1996 | - | $4.10M(-2.4%) |
| Mar 1996 | - | $4.20M(+40.0%) |
| Dec 1995 | $3.00M(+114.3%) | $3.00M(-47.4%) |
| Sep 1995 | - | $5.70M(-1.7%) |
| Jun 1995 | - | $5.80M(+61.1%) |
| Mar 1995 | - | $3.60M(+157.1%) |
| Dec 1994 | $1.40M(-60.0%) | $1.40M(-65.9%) |
| Sep 1994 | - | $4.10M(+13.9%) |
| Jun 1994 | - | $3.60M(+28.6%) |
| Mar 1994 | - | $2.80M(-20.0%) |
| Dec 1993 | $3.50M(+400.0%) | $3.50M(+29.6%) |
| Sep 1993 | - | $2.70M(+42.1%) |
| Jun 1993 | - | $1.90M(-24.0%) |
| Mar 1993 | - | $2.50M(+257.1%) |
| Dec 1992 | $700.00K(-12.5%) | $700.00K(-41.7%) |
| Jun 1992 | - | $1.20M(+20.0%) |
| Mar 1992 | - | $1.00M(+25.0%) |
| Dec 1991 | $800.00K | $800.00K(-11.1%) |
| Sep 1991 | - | $900.00K(0.0%) |
| Jun 1991 | - | $900.00K |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual accounts payable?
- What is the all time high annual accounts payable for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual accounts payable year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly accounts payable?
- What is the all time high quarterly accounts payable for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly accounts payable year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual accounts payable?
The current annual accounts payable of VRTX is $413.00M
What is the all time high annual accounts payable for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual accounts payable is $413.00M
What is Vertex Pharmaceuticals Incorporated annual accounts payable year-on-year change?
Over the past year, VRTX annual accounts payable has changed by +$48.10M (+13.18%)
What is Vertex Pharmaceuticals Incorporated quarterly accounts payable?
The current quarterly accounts payable of VRTX is $445.00M
What is the all time high quarterly accounts payable for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly accounts payable is $445.00M
What is Vertex Pharmaceuticals Incorporated quarterly accounts payable year-on-year change?
Over the past year, VRTX quarterly accounts payable has changed by +$93.60M (+26.64%)